The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Adverse drug reactions
Dermatological reactions represent the most consistently documented side effect of excessive B12 intake
Adding warm or room-temperature bac water to lyophilized peptide can cause partial denaturation on contact
This product is intended for cosmetic use only and is not intended to diagnose, treat, cure, or prevent any disease
J Mol Cell Cardiol 191:5062 Gandin V, English BP, Freeman M, Leroux L-P, Preibisch S, Walpita D, Jaramillo M, Singer RH (2022) Cap-dependent translation initiation monitored in living cells
